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Edited by Veli-Pekka LehtoAbstract The hepatocyte growth factor (HGF) receptor, Met,
is frequently overexpressed in nasopharyngeal cancer (NPC).
Here, we showed for the ﬁrst time that human NPC cells with
high Met expression were more sensitive to the cell motility
and invasion eﬀect of HGF. The downregulation of Met by small
interfering RNA decreased tumor cell invasion/migration. HGF
signiﬁcantly increased matrix metalloproteinase-9 production.
This was inhibited by blocking phosphatidylinositide 3-kinase
(PI3K) and c-Jun N-terminal kinase (JNK), but not extracellu-
lar signal-regulated kinase 1/2 and p38 mitogen-activated protein
kinase signaling pathways. We also demonstrated that PI3K in-
duced activation of JNK, with Akt as a potential point of this
cross-talk. These results provide new insights into the molecular
mechanism responsible for NPC progression and metastasis.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Nasopharyngeal cancer (NPC) is one of the most common
fatal cancers, especially in Southern China and Southeast Asia
where the incidence is approximately 30–80/100,000 people per
year (30-fold higher than worldwide) [1]. In addition to its ra-
pid growth behavior, NPC has a great tendency to invade adja-
cent regions and metastasize to regional lymph node and
distant organs. As a result, most (60–85%) NPC patients al-
ready have advanced disease when diagnosed [1] and this leads
to a high rate of treatment failure. Thus there is a need for new
therapeutic targets and a better understanding of the mecha-
nisms involved in the spread of NPC.
The expression of hepatocyte growth factor (HGF) receptor,
encoded by the Met oncogene, is frequently overexpressed in
NPC. Importantly, Met expression is often elevated in NPC
metastases than in primary lesions, and higher Met protein
expression is associated with shorter patient survival time
[2,3]. In addition, HGF is abundantly detected in the interstitial
tissues surrounding the tumor [2], which further suggests that
NPC could progress or metastasize through activation of the
HGF-Met system. However, a role for HGF in NPC cell migra-*Corresponding author. Fax: +852 2559 9114.
E-mail address: awong1@hku.hk (A.S.T. Wong).
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doi:10.1016/j.febslet.2008.09.004tion/invasion has not been established and the mechanism by
which HGF contributes to NPC invasiveness is also unknown.
In this study, we show for the ﬁrst time a direct role for HGF
in the invasive phenotype and motility of NPC cells. We fur-
ther demonstrate that the availability of Met receptor modiﬁes
NPC cell response to HGF. We have also identiﬁed a novel
mechanism for HGF-induced invasion and migration, which
is mediated by JNK through regulation of matrix metallopro-
teinase (MMP)-9 in response to PI3K/Akt signaling.2. Materials and methods
2.1. Cell culture and treatments
The human NPC cell lines, CNE-2, HK-1, and C666-1, were grown
in RPMI 1640 supplemented with 10% FBS, 50 U/ml penicillin, and
50 lg/ml streptomycin. The cells were incubated in 5% CO2 at 37 C.
To elucidate the underlying signal transduction mechanism, cells were
preincubated for 30 min with or without various inhibitors (50 nM
K252a, 10 lM SB-3CT, 25 lM LY294002, 200 nM wortmannin,
20 nM rapamycin, 50 lM PD98059, 10 lM SB203580, or 50 lM
SP600125) (Calbiochem) or 10 lg/ml MMP-9 neutralizing antibody
(Calbiochem) prior to the addition of human recombinant HGF
(R&D Systems). Cells were transfected with dominant negative Akt
(Upstate), or Met siRNA (5 0-ACUCUAGAUGCUCAGACUU-3 0)
[4] (Dharmacon) using Lipofectamine 2000 reagent (Invitrogen)
according to the manufacturers instructions. After 24 h, the cells were
collected for Western blotting or biological assays.
2.2. Cell invasion and migration assays
Cells (1 · 105) were seeded onto the Matrigel-coated ﬁlters (BD Bio-
sciences) and incubated in serum-free medium with 10 ng/ml HGF for
24 h. Non-invading cells on the upper side of the ﬁlters were removed
with moistened cotton swab. Cells that penetrated the membrane were
ﬁxed with ice-cold methanol, stained with 0.5% crystal violet, photo-
graphed, and counted under the microscope. To assess cellular migra-
tion potential, the protocol described above was used, except that
Matrigel was omitted.
2.3. Semi-quantitative RT-PCR
Total RNA was extracted by the Trizol reagent, and RT was per-
formed using the SuperScript II kit (Invitrogen, Carlsbad, CA) follow-
ing the manufacturer 0s instruction. The cDNAwas used for subsequent
PCR using primers speciﬁc for human MMP-2 (5 0-GGCCCTGTCA-
CTCCTGAGAT-3 0, and 5 0-GGCATCCAGGTTATGGGGGA-3 0),
or MMP-9 (5 0-CAACATCACCTATTGGATCC-3 0 and 5 0-CGGGT-
GTAGAGTCTCTCGCT-3 0), or TIMP-1 (5 0-CTGGCTTCTGGCAT
CCTGTTG-30 and 5 0-AACTCCTCGCTGCGGTTCTG-3 0), or
TIMP-2 (5 0-GCGGTCAGTGAGAAGGAAGTGG-3 0 and 5 0-
CTTGCACT CGCAGCCCATCTG-30). b-Actin was an internal stan-
dard. The number of ampliﬁcation cycles during which PCR product
formation was limited by template concentration, was determined in pi-
lot experiments.blished by Elsevier B.V. All rights reserved.
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Proteins (40 lg) were subjected to SDS–PAGE, and then transferred
to nitrocellulose membrane. Immunoblotting was performed with the
appropriate primary antibodies, and detected with horseradish peroxi-
dase-conjugated IgG as secondary antibody. Monoclonal antibody to
Met (25H2) was from Cell Signaling, monoclonal antibodies to
MMP-2 and MMP-9, TIMP-1 and TIMP-2 were from Chemicon.
The polyclonal phospho-speciﬁc antibodies to Akt(S473), p70S6K(T389),
ERK1/2(T202/Y204), p38 MAPK(T180/Y182), JNK(T183/Y185), and poly-
clonal anti-Akt, anti-ERK1/2, anti-p38 MAPK, and anti-JNK were
purchased from Cell Signaling. The c-myc (9E10) antibody was from
Sigma. Blots were developed with an enhanced chemiluminescence sys-
tem (Amersham).
2.5. Gelatin zymography
Aliquots (80 lg) of conditioned media were loaded on SDS–PAGE
gels containing 0.1% gelatin under non-reducing conditions. The gels
were incubated overnight at 37 C in the developing buﬀer containing
50 mM Tris–HCl and 20 mM CaCl2, pH 7.4. They were visualized by
staining the gel with 0.5% Coomassie Brilliant Blue R-250 for 6 h and,
subsequently, destaining of the gel until bands became clear.
2.6. Statistical analysis
All experiments were repeated at least three times. Data were ex-
pressed as means ± S.D. and compared by one-way ANOVA and Tu-
keys least signiﬁcant diﬀerence post-test (GraphPad Software, San
Diego, CA). P < 0.05 was considered statistically signiﬁcant.3. Results
3.1. Inhibition of Met expression is associated with reduced
invasion of NPC cells
CNE-2 used in this study is a representative NPC cell line that
is derived from a poorly diﬀerentiated EBV-positive NPCwhich
expresses high levels ofMet and responds toHGFby phosphor-
ylation of the Met receptor [2,5]. Since Met mediates motile sig-
nals, we set out to investigate whether downregulation of Met
by siRNA could aﬀect cell invasion and migration in response
to HGF. The speciﬁcity of Met siRNA to inhibit the Met pro-
tein was conﬁrmed by Western blotting (Fig. 1A). HGF signif-
icantly stimulated CNE-2 cells to migrate through theMatrigel,
suggesting enhanced invasive capacity comparedwith untreated
controls. Importantly, inhibition of Met expression by siRNA
completely prevented HGF-induced cell invasion, while non-
speciﬁc siRNA had no eﬀect (Fig. 1B). We also assessed
in vitro migration in response to Met siRNA using a transwell
migration assay. Consistently, cells with silencedMet abolished
the HGF-induced cell migration in contrast with cells transfec-
ted with nonspeciﬁc siRNA (Fig. 1C). Pretreatment of cells with
K252a, a chemical inhibitor that suppressedMet kinase activity
[6], had a similar inhibitory eﬀect as Met siRNA (Figs. 1B and
1C). In line with this, we also observed pronounced morpholog-
ical changes as revealed by loss of cell–cell contact and spindle-
shaped or ﬁbroblastic cell morphology (scattering), suggesting
enhanced spreading and migration capacity of HGF (Fig. S1).
There was no signiﬁcant change in cell proliferation under these
conditions by using the MTT assay (Fig. S1). Together, these
data indicate thatMet overexpression enhances the invasiveness
of NPC cells.
3.2. HGF induces MMP-9 expression and enhances its activity
MMP-2 and MMP-9 are well-documented ECM-degrading
enzymes and whose activities are associated with NPC tumor
invasiveness [7,8]. To investigate whether they play a role in
the HGF-stimulated cell invasion, MMP-2 and MMP-9 pro-tein and enzymatic activities were measured by Western blot-
ting and gelatin zymography. As shown, the expression
(Fig. 2A) and activity (Fig. 2B) of MMP-2 was not signiﬁ-
cantly altered by HGF, nor did it aﬀect the expression of
TIMP-2 (Fig. 2A). In contrast to MMP-2, both expression
and proteolytic activity of MMP-9 was found to be dramati-
cally elevated after HGF treatment (Fig. 2A–C). There was
however no change in protein and mRNA levels for TIMP-1
(Fig. 2A and C).
3.3. Inhibition of MMP-9 blocks HGF-enhanced invasion
To evaluate the potential contribution of MMP-9 in the
HGF-induced invasion of NPC cells, we tested the ability of
the potent MMP-9 speciﬁc inhibitor (SB-3CT) or MMP-9 neu-
tralizing antibody to inhibit the HGF-mediated eﬀects on the
invasiveness of CNE-2. Speciﬁc blocking of MMP-9 activity
abolished the increase in invaded cells after HGF treatment
(Fig. 2D). Similar results were obtained in migration assays
(data not shown). MTT assay revealed no signiﬁcant eﬀect
on the growth of treated cells and controls (Fig. S2). These re-
sults suggest that MMP-9 plays a critical role in mediating the
eﬀects of HGF on the ability of CNE-2 cells to invade the base-
ment membrane matrix.
3.4. Activation of the PI3K/Akt and JNK signaling pathways
regulates invasion
To investigate the mechanism involved in HGF-induced
invasion of CNE-2 cells, we studied the eﬀects of various phar-
macological inhibitors on HGF-stimulated invasion. Our data
showed that inhibition of PI3K activation by 200 nM wort-
mannin (data not shown) or 25 lM LY294002 eﬀectively im-
peded HGF-stimulated invasion (Fig. 3A) and cell scattering
(Fig. S3), suggesting that the PI3K pathway is required for
NPC cell invasiveness. This result was not due to the inhibition
of proliferation (Fig. S3). Akt is the primary signal mediator of
PI3K. Activation of PI3K/Akt stimulates multiple signal trans-
duction mechanisms, including p70S6K. Although HGF stimu-
lation of NPC induced p70S6K phosphorylation (Fig. 3B),
inhibition of the mTOR/p70S6K pathway by 20 nM rapamycin
did not aﬀect NPC cellular invasion (Fig. 3A) or scattering
(Fig. S3) induced by HGF.
Because studies have shown that the MAPK pathway is crit-
ical for the activation of gene expression and cell migration by
HGF in some cell types [9,10], we asked if they also play a role
in HGF-induced human NPC cell invasion and/or migration.
As shown, addition of HGF to the cells signiﬁcantly increased
the phosphorylation of ERK1/2, p38 MAPK, and JNK
(Fig. 4A). However, it was only treatment of 50 lM
SP600125, a speciﬁc JNK inhibitor, signiﬁcantly reduced the
number of invaded (Fig. 4B) and scattered (Fig. S3) cells to
near basal levels. SP600125 did not alter cell proliferation
(Fig. S3). In contrast, inhibition of HGF-stimulated ERK1/2
and p38 MAPK activation by 50 lM PD98059 or 10 lM
SB203580, respectively, had no eﬀect (Fig. 4B and Fig. S3).
Similar results were also obtained with a diﬀerent MEK inhib-
itor U0126 and with a diﬀerent p38 MAPK inhibitor SB202190
(data not shown). Interestingly, LY294002 was able to prevent
JNK phosphorylation. In contrast, the level of Akt was not af-
fected when the JNK pathway was inhibited by SP600125
(Fig. 4C). These data suggest that PI3K/Akt is an upstream ki-
nase of JNK in NPC.
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Fig. 1. Met overexpression mediates HGF-induced invasion and migration. (A) CNE-2 cells were transiently transfected with Met siRNA or
nonspeciﬁc siRNA (NS siRNA) as control. Met expression was analyzed by immunoblotting. (B) Cells were also incubated untreated or treated with
HGF, in either the presence or absence of K252a. In parallel experiments, they were subjected to invasion assay through Matrigel-precoated ﬁlter and
(C) migration assay through uncoated ﬁlter. Representative pictures were shown in the left panel. The bar graphs (right panel) represent the mean
number of invaded or migrated cells of ﬁve ﬁelds ± S.D. of triplicate wells from three independent experiments. Bar, 100 lm. *P < 0.05 compared
with HGF alone.
H.Y. Zhou et al. / FEBS Letters 582 (2008) 3415–3422 3417To conﬁrm JNK is a downstream molecule of Akt that medi-
ates the invasive response, the eﬀects of expressing dominant
negative Akt (DN-Akt) on cellular invasion were studied. Spe-
ciﬁc inactivation of Akt in DN-Akt transfectants was con-
ﬁrmed by Western blotting (Fig. 5A). Expression of DN-Akt
prevented the phosphorylation of JNK (Fig. 5A) and decreasedHGF-induced MMP-9 production (Fig. 5B) and cell invasion
(Fig. 5C), demonstrating that HGF transmits an invasion sig-
nal through Akt to JNK. Similar results were also obtained
when these experiments were done in HK-1 and C666-1 NPC
cell lines, indicating that these ﬁndings were not merely due
to a cell line-speciﬁc phenotype (data not shown).
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Fig. 2. HGF induces production and synthesis of MMP-9. (A) MMP-2 and MMP-9 proteins were analyzed by Western blot. b-actin was included as
loading control. (B) Conditioned medium from HGF-untreated or treated cells were also collected and analyzed for MMP activities by gelatin
zymography. (C) Cells were harvested for semi-quantitative RT-PCR with speciﬁc primers as described in Materials and methods. The signal
intensity was determined by densitometry, and the levels of MMP-9, MMP-2, TIMP-1, and TIMP-2 were normalized against that of b-actin. (D)
Cells were left untreated or pretreated with SB-3CT or neutralizing MMP-9 antibody (anti-MMP-9) for 30 min. Cells were then were subjected to
invasion assay in the presence or absence of HGF. Representative pictures were shown in the left panel. The bar graph (right panel) represents the
mean number of invaded cells of ﬁve ﬁelds ± S.D. of triplicate wells from three independent experiments. Bar, 100 lm. *P < 0.05 compared with
HGF alone.
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Distant metastasis of NPC is more frequent than most of
other head and neck cancers and it remains the most common
reason for treatment failure and poor prognosis of the patients
with late-stage NPC [1]. In this study, we explored for the ﬁrsttime a direct role of Met in NPC progression. We found that
HGF increased the transformed phenotype of NPC cells by
promoting cell migration and invasion. These intriguing ﬁnd-
ings are relevant to a large number of NPC because the Met
receptor for HGF is commonly overexpressed in human
NPC and HGF is abundantly detected in the interstitial tissues
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Fig. 3. Inhibition of PI3K inhibits HGF-induced cell invasion. (A) Cells were preincubated with LY294002 (LY) or rapamycin (Rp) for 30 min and
then subjected to invasion assay in the presence or absence of HGF. Representative pictures were shown in the left panel. The bar graph (right panel)
represents the mean number of invaded cells of ﬁve ﬁelds ± S.D. of triplicate wells from three independent experiments. Bar, 100 lm. *P < 0.05
compared with HGF alone. (B) Cells were exposed to 10 ng/ml HGF for the indicated durations. Activities of Akt and p70S6K were determined by
Western blotting. Total non-phosphorylated enzymes and b-actin were used as internal controls. The relative intensity of phosphorylated (p-) forms
of Akt and p70S6K was normalized to total values of Akt and p70S6K, which were determined by densitometric analysis.
H.Y. Zhou et al. / FEBS Letters 582 (2008) 3415–3422 3419surrounding the tumor [2]. Moreover, we show that the cross-
talk between PI3K/Akt and JNK pathways is required for
NPC cell invasion, providing an insight into the prospect of
developing targeted therapy for NPC.
HGF receptor activation stimulates multiple downstream
signals, including PI3K/Akt. The most interesting aspect of
this work was the ﬁnding that while PI3K/Akt and JNK are
two parallel pathways in some cell types, we show that they
are two related pathways in NPC, since inhibition of PI3K/
Akt can alter activation of JNK. The cross-talk between
PI3K/Akt and JNK is just emerging. In contrast to most stud-
ies [11–13], in which JNK was inhibited when PI3K/Akt was
activated, our present studies provide a new mechanism where-
by stimulation of PI3K/Akt activated the JNK pathway and
this positive regulation is important for the invasive and met-
astatic growth of NPC. Unlike Akt, involvement of JNK in
cell invasiveness or migration has not been reported exten-
sively. JNK-dependent signaling molecules were recently
shown to regulate invasive behavior and MMP-9 production
of human gliomas [14]. Interestingly, JNK is also shown to
be speciﬁcally involved in Epstein–Barr viral protein-mediated
cellular transformation [15,16]. How JNK controls invasion/
cell migration is still not clear. One possibility is through
changes in gene expression. JNK has been well established as
a key regulator of transcription through AP-1 and SP-1 bind-ing sites [17,18]. The MMP-9 gene shown in this study to be
regulated by Met is also, at least in part, regulated transcrip-
tionally through very similar mechanisms [19]. JNK could also
regulate cell migration through direct signaling to the cytoskel-
eton. Earlier studies in Drosophila have shown that JNK di-
rectly interacts with and phosphorylates the actin-associated
Spir 150, a WASP family protein that might connect JNK
activity to actin cytoskeleton [20]. A direct link between JNK
and actin cytoskeleton has recently been found in mammals,
with the observation that JNK phosphorylates paxillin, an ac-
tin-associated protein [21]. In addition, it is known that HGF
promotes expression of angiogenesis factors interleukin-8 and
vascular endothelial growth factor in head and neck cancer cell
lines through both MAPK- and PI3K-dependent pathways
[22]. Whether blocking the HGF/Met pathway may beneﬁt
the tumor treatment in NPC patients via inhibiting angiogen-
esis in addition to inhibiting tumor cell invasion and migration
is worthwhile for future investigation.
Our data show that HGF plays a role in modulating the
expression of MMP-9 in NPC. MMP-9 activity is an impor-
tant determinant of NPC invasion and metastasis. Upregula-
tion of MMP-9 is found in patients with advanced-stage
NPC [8]. Furthermore, it has been reported that several Ep-
stein–Barr viral proteins can activate the MMP-9 [3,23,24]. Be-
sides its role in cell invasion, MMP-9 can promote tumor
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Fig. 4. Inhibition of JNK inhibits HGF-induced cell invasion. (A) Cells were exposed to HGF for the indicated durations. Activities of ERK1/2, p38
MAPK, and JNK were determined by Western blotting using antibodies speciﬁc for phosphorylated (p-) forms of ERK1/2, p38 MAPK, and JNK.
Total non-phosphorylated enzymes and b-actin were used as internal controls. The signal intensity was determined by densitometry, and the levels of
p-ERK1/2, p-p38 MAPK, and p-JNK were normalized against total ERK1/2, JNK, and p38 MAPK. (B) Cells were preincubated with PD98059
(PD), SB203580 (SB), or SP600125 (SP) before they were subjected to invasion assay in the presence or absence of HGF. Representative pictures were
shown in the left panel. The bar graph (right panel) represents the mean number of invaded cells of ﬁve ﬁelds ± S.D. of triplicate wells from three
independent experiments. (C) Cells were preincubated with LY294002 (LY) or SP for 30 min and then stimulated with HGF for further 15 min.
Whole cell lysates were analyzed by immunoblotting with phosphorylated and total Akt and JNK. Immunoblotting for b-actin was used as loading
control. The signal intensity was determined by densitometry, and the levels of p-Akt and p-JNK were normalized against total Akt and JNK.
*P < 0.05 compared with HGF alone.
3420 H.Y. Zhou et al. / FEBS Letters 582 (2008) 3415–3422migration by inﬂuencing cytoskeletal organization through
their association with diﬀerent families of adhesion receptors
[25], and angiogenesis via vascular endothelial growth factorproduction [26]. MMPs expression is often coordinately regu-
lated with production of their endogenous inhibitors, TIMPs.
Surprisingly, activation of MMP-9 was not related to a de-
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H.Y. Zhou et al. / FEBS Letters 582 (2008) 3415–3422 3421crease in the speciﬁc inhibitor of TIMP-1 in CNE-2 cells. How-
ever, as there is an increase in the MMP-9/TIMP-1 ratio, this
reﬂects a net increase in MMP-9 activity, which may also favor
ECM degradation.
In summary, our ﬁndings emphasize the potential role of
overexpression of the Met receptor in promoting cellular
migration and matrix-degrading activities in NPC cells. This
information provides a mechanistic rationale for the observed
Met overexpression in advanced-stage NPC. The cross-talk be-
tween PI3K/Akt and JNK represents a new mechanism for
enhancing the invasiveness of NPC and may contribute to de-
velop improved and more speciﬁc therapeutics for the treat-
ment of NPC.
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